Cargando…

Delivery of CdiA Nuclease Toxins into Target Cells during Contact-Dependent Growth Inhibition

Bacterial contact-dependent growth inhibition (CDI) is mediated by the CdiB/CdiA family of two-partner secretion proteins. CDI systems deploy a variety of distinct toxins, which are contained within the polymorphic C-terminal region (CdiA-CT) of CdiA proteins. Several CdiA-CTs are nucleases, suggest...

Descripción completa

Detalles Bibliográficos
Autores principales:	Webb, Julia S., Nikolakakis, Kiel C., Willett, Julia L. E., Aoki, Stephanie K., Hayes, Christopher S., Low, David A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585180/ https://www.ncbi.nlm.nih.gov/pubmed/23469034 http://dx.doi.org/10.1371/journal.pone.0057609

Ejemplares similares

CdiA Effectors from Uropathogenic Escherichia coli Use Heterotrimeric Osmoporins as Receptors to Recognize Target Bacteria
por: Beck, Christina M., et al.
Publicado: (2016)

Lipidation of Class IV CdiA Effector Proteins Promotes Target Cell Recognition during Contact-Dependent Growth Inhibition
por: Halvorsen, Tiffany M., et al.
Publicado: (2021)

CdiA Effectors Use Modular Receptor-Binding Domains To Recognize Target Bacteria
por: Ruhe, Zachary C., et al.
Publicado: (2017)

Capsule Protects Acinetobacter baumannii From Inter-Bacterial Competition Mediated by CdiA Toxin
por: Krasauskas, Renatas, et al.
Publicado: (2020)

Erratum: Capsule Protects Acinetobacter baumannii From Inter-Bacterial Competition Mediated by CdiA Toxin
Publicado: (2020)

Identification of Functional Toxin/Immunity Genes Linked to Contact-Dependent Growth Inhibition (CDI) and Rearrangement Hotspot (Rhs) Systems
por: Poole, Stephen J., et al.
Publicado: (2011)

Genetic Evidence for SecY Translocon-Mediated Import of Two Contact-Dependent Growth Inhibition (CDI) Toxins
por: Jones, Allison M., et al.
Publicado: (2021)

A widespread family of polymorphic contact-dependent toxin delivery systems in bacteria
por: Aoki, Stephanie K., et al.
Publicado: (2010)

Class II contact‐dependent growth inhibition (CDI) systems allow for broad‐range cross‐species toxin delivery within the Enterobacteriaceae family
por: Virtanen, Petra, et al.
Publicado: (2019)

Functional Characterization of Pseudomonas Contact Dependent Growth Inhibition (CDI) Systems
por: Mercy, Chryslène, et al.
Publicado: (2016)

Correction: Functional Characterization of Pseudomonas Contact Dependent Growth Inhibition (CDI) Systems
por: Mercy, Chryslène, et al.
Publicado: (2016)

CDI Systems Are Stably Maintained by a Cell-Contact Mediated Surveillance Mechanism
por: Ruhe, Zachary C., et al.
Publicado: (2016)

The CDI toxin of Yersinia kristensenii is a novel bacterial member of the RNase A superfamily
por: Batot, Gaëlle, et al.
Publicado: (2017)

Fidaxomicin Preserves the Intestinal Microbiome During and After Treatment of Clostridium difficile Infection (CDI) and Reduces Both Toxin Reexpression and Recurrence of CDI
por: Louie, Thomas J., et al.
Publicado: (2012)

Genetic Analysis of the CDI Pathway from Burkholderia pseudomallei 1026b
por: Koskiniemi, Sanna, et al.
Publicado: (2015)

Biofilm Formation of Clostridioides difficile, Toxin Production and Alternatives to Conventional Antibiotics in the Treatment of CDI
por: Dicks, Leon M. T.
Publicado: (2023)

Identification of a Contact-Dependent Growth Inhibition (CDI) System That Reduces Biofilm Formation and Host Cell Adhesion of Acinetobacter baumannii DSM30011 Strain
por: Roussin, Morgane, et al.
Publicado: (2019)

Structural insight into toxin secretion by contact-dependent growth inhibition transporters
por: Guerin, Jeremy, et al.
Publicado: (2020)

Receptor Polymorphism Restricts Contact-Dependent Growth Inhibition to Members of the Same Species
por: Ruhe, Zachary C., et al.
Publicado: (2013)

Targeted intracellular delivery of Cas13 and Cas9 nucleases using bacterial toxin-based platforms
por: Tian, Songhai, et al.
Publicado: (2022)

Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI
por: Finn, Elaine, et al.
Publicado: (2021)

Doctor, my patient has CDI and should continue to receive antibiotics. The (unresolved) risk of recurrent CDI
por: Castro, Iván, et al.
Publicado: (2019)

Toxin Detection by Cell Culture Neutralization Assay [CYT] and Toxin based EIA [Tox EIA] among Recurrent Episodes of CDI Diagnosed by PCR
por: Kamboj, Mini, et al.
Publicado: (2017)

A point-prevalence study on community and inpatient Clostridioides difficile infections (CDI): results from Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI), July to November 2018
por: Viprey, Virginie F, et al.
Publicado: (2022)

JBoss Weld CDI for Java platform
por: Finnegan, Ken
Publicado: (2013)

Focusing stewardship to help tackle CDI
Publicado: (2020)

Introducing Jakarta EE CDI: Contexts and Dependency Injection for Enterprise Java Development
por: Saeed, Luqman
Publicado: (2020)

SMT19969 for Clostridium difficile infection (CDI): in vivo efficacy compared with fidaxomicin and vancomycin in the hamster model of CDI
por: Sattar, Abdul, et al.
Publicado: (2015)

684. Characteristics of Patients with Initial Clostridioides difficile Infection (CDI) That Are Associated With Increased Risk of Multiple CDI Recurrences
por: Guh, Alice, et al.
Publicado: (2023)

135. Impact of Clostridioides difficile Toxin Confirmation on Subsequent C. difficile Treatment in a Rural Health System (IT-CDI)
por: Crawford, Jacquelyn, et al.
Publicado: (2023)

Functional plasticity of antibacterial EndoU toxins
por: Michalska, Karolina, et al.
Publicado: (2018)

Use of Electronic Data to Identify Risk Factors Associated with Clostridium difficile Infection (CDI) and to Develop CDI Risk Scores
por: Aukes, Laurie, et al.
Publicado: (2017)

Pro CDI 2 in Java EE 8: an in-depth guide to context and dependency injection
por: Beernink, Jan, et al.
Publicado: (2019)

Bezlotoxumab (BEZ) for Prevention of Clostridium Difficile Infection (CDI) Recurrence (rCDI): Outcomes in Patients with Substantial Renal Impairment (SRI)
por: Golan, Yoav, et al.
Publicado: (2017)

Receptor-mediated delivery of engineered nucleases for genome modification
por: Chen, Zhong, et al.
Publicado: (2013)

Selection of Orphan Rhs Toxin Expression in Evolved Salmonella enterica Serovar Typhimurium
por: Koskiniemi, Sanna, et al.
Publicado: (2014)

1211. Response to Fecal Microbiota Transplant (FMT) in Refractory Clostridioides difficile Infection (CDI) is Modest Compared to Recurrent CDI in Hospitalized Patients
por: Shin, Jae Hyun, et al.
Publicado: (2020)

Functional and Structural Diversity of Bacterial Contact-Dependent Growth Inhibition Effectors
por: Cuthbert, Bonnie J., et al.
Publicado: (2022)

Mechanisms of typhoid toxin neutralization by antibodies targeting glycan receptor binding and nuclease subunits
por: Ahn, Changhwan, et al.
Publicado: (2021)

New advances in the treatment of Clostridium difficile infection (CDI)
por: Hedge, Dennis D, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_8iq251a7jtse6fou69e6lrlc2d